Plasma Fractionation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018-2025

Plasma Fractionation Market:

Executive Summary

Global Plasma Fractionation Market valued approximately USD 19 million in 2016 is anticipated to grow with a healthy growth rate of more than 6.50% over the forecast period 2017-2025. Key factors which are providing growth to the market are the increasing use of immunoglobulins in several therapeutic areas, increasing respiratory diseases, growing geriatric population across the world, and AATD driving the approval of alpha-1-antitrypsin, and growing plasma collection. However, limited reimbursement policies and high cost, are the major restraining factor which hinder the growth of this market.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Products:

• Immunoglobulin
• Coagulation Factor Concentrates
• Albumin
• Protease Inhibitors
• Others

By Application:

• Neurology
• Immunology
• Homology
• Critical Care
• Pulmonology
• Hemoto-Oncology
• Rheumatology
• Others

By End Use:

• Hospitals & Clinics
• Clinical Research Laboratories
• Academic Institutes

Furthermore, years considered for the study are as follows:

• Historical year – 2015
• Base year – 2016
• Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market CSL, Grifols, Shire, Octapharma, Kedrion, LFB, Biotest, Sanquin, China Biologic Products, Bio Prodcuts Laboratory (BPO), Japan Blood Products Organization, Green Cross Corporation, Shanghai Raas Blood Products Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Plasma Fractionation Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Request Sample Report @ https://www.wiseguyreports.com/sample-request/3180973-global-plasma-fractionation-market-size-study-by-product

Table of Contents

Chapter 1. Global Plasma Fractionation Market Definition and Scope 
    1.1. Research Objective 
    1.2. Market Definition 
    1.3. Scope of The Study 
    1.4. Years Considered for The Study 
    1.5. Currency Conversion Rates 
    1.6. Report Limitation 

Chapter 2. Research Methodology 
    2.1. Research Process 
      2.1.1. Data Mining 
      2.1.2. Analysis 
      2.1.3. Market Estimation 
      2.1.4. Validation 
      2.1.5. Publishing 
    2.2. Research Assumption 

Chapter 3. Executive Summary 
    3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion) 
    3.2. Key Trends 

Chapter 4. Global Plasma Fractionation Market Dynamics 
    4.1. Growth Prospects 
      4.1.1. Drivers 
      4.1.2. Restraints 
      4.1.3. Opportunities 
    4.2. Industry Analysis 
      4.2.1. Porter’s 5 Force Model 
      4.2.2. PEST Analysis 
      4.2.3. Value Chain Analysis 
    4.3. Analyst Recommendation & Conclusion

Chapter 5. Global Plasma Fractionation Market, By Product

Chapter 6. Global Plasma Fractionation Market, By Application

Chapter 7. Global Plasma Fractionation Market, By End Use

Chapter 8. Global Plasma Fractionation Market, by Regional Analysis 

Chapter 9. Competitive Intelligence 
    9.1. Company Market Share (Subject to Data Availability) 
    9.2. Top Market Strategies 
    9.3. Company Profiles 
      9.3.1. CSL 
          9.3.1.1. Overview 
          9.3.1.2. Financial (Subject to Data Availability) 
          9.3.1.3. Product Summary 
          9.3.1.4. Recent Developments 
      9.3.2. Grifols 
      9.3.3. Shire 
      9.3.4. Octapharma 
      9.3.5. Kedrion 
      9.3.6. LFB 
      9.3.7. Biotest 
      9.3.8. Sanquin 
      9.3.9. China Biologic Products 
      9.3.10. Bio Prodcuts Laboratory (BPO) 
      9.3.11. Japan Blood Products Organization 
      9.3.12. Green Cross Corporation 
      9.3.13. Shanghai Raas Blood Products

 Continuous…

For further information on this report, visit – https://www.wiseguyreports.com/reports/3180973-global-plasma-fractionation-market-size-study-by-product

Contact Us:

Norah Trent           

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US); +44 208 133 9349 (UK)